Skip navigation
Please use this identifier to cite or link to this item:
Files in This Item:
There are no files associated with this item.
Title: New perspectives on the topical management of recurrent candidiasis
Authors: Ré, Ana Carolina S.
Martins, Jayanaraian F.
Cunha Filho, Marcílio Sérgio Soares da
Gelfuso, Guilherme Martins
Aires, Carolina P.
Gratieri, Taís
Assunto:: Candidíase
Tecnologia farmacêutica
Issue Date: 19-Jan-2021
Publisher: Springer Nature
Citation: RÉ, Ana Carolina S. et al. New perspectives on the topical management of recurrent candidiasis. Drug Delivery and Translational Research, 2021. DOI:
Abstract: Candidiasis is a common opportunistic infection caused by fungi of the Candida genus that affects mainly mucocutaneous tissues (e.g., vaginal, oral, and mammary). This condition has been known for a long time; thus, innumerous topical and systemic treatments are already available on the market worldwide. Yet, recurrent superficial candidiasis (RSC) is an expected outcome, still lacking effective and convenient treatments. Although several individual conditions may contribute to disease recurrence, biofilms’ presence seems to be the main etiological factor contributing to antifungal resistance. More than proposing novel antifungal agents, current research seems to be focusing on improving the pharmaceutical technology aspects of formulations to address such a challenge. These include extending and improving intimate contact of drug delivery systems with the mucocutaneous tissues, increasing drug loading dose, and enhancing topical drug permeation. This review discusses the current understanding of the RSC and the use of pharmaceutical technology tools in obtaining better results. Even though several drawbacks of conventional formulations have been circumvented with the help of nano- or microencapsulation techniques and with the use of mucoadhesive formulation excipients, many challenges remain. In particular, the need to mask the unpalatable taste of formulations for the treatment of oral candidiasis, and the necessity of formulations with a “dryer” sensorial feeling and improved performances in providing higher bioavailability for the treatment of mammary and vaginal candidiasis.
Appears in Collections:FAR - Artigos publicados em periódicos

Show full item record Recommend this item " class="statisticsLink btn btn-primary" href="/handle/10482/40964/statistics">

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.